Top-News

ALABAMA POWER CO 5.875% SR NOT News

Aktie
WKN:  A0YDWF ISIN:  US0103924967
Keine aktuellen Kursdaten verfügbar
Handeln Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Aktienanzahl *
-
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-

ALABAMA POWER CO 5.875% SR NOT News

09.05.22 - PR Newswire
Almirall delivers good business performance in Q1 and reiterates full year 2022 guidance
Almirall delivers good business performance in Q1 and reiterates full year 2022 guidance PR Newswire
11.04.22 - PR Newswire
Almirall: Lebrikizumab Combined with Topical Corticosteroids Showed Significant Improvements in Disease Severity for Atopic Dermatitis
Almirall: Lebrikizumab Combined with Topical Corticosteroids Showed Significant Improvements in Disease Severity for Atopic Dermatitis PR Newswire
26.03.22 - PR Newswire
Almirall: Majority of Patients Treated with Lebrikizumab Achieved Skin Clearance in Pivotal Phase 3 Atopic Dermatitis Studies
Almirall: Majority of Patients Treated with Lebrikizumab Achieved Skin Clearance in Pivotal Phase 3 Atopic Dermatitis Studies PR Newswire
21.02.22 - PR Newswire
Dr. Jorge Gallardo Ballart announces his intention to retire from his positions of President of the Board of Directors and Board member of Almirall
Dr. Jorge Gallardo Ballart announces his intention to retire from his positions of President of the Board of Directors and Board member of Almirall PR Newswire
21.02.22 - PR Newswire
Dr. Jorge Gallardo Ballart announces his intention to retire from his positions of President of the Board of Directors and Board member of Almirall
Dr. Jorge Gallardo Ballart announces his intention to retire from his positions of President of the Board of Directors and Board member of Almirall The resignation will be effective as ...
21.02.22 - PR Newswire
Almirall's Full-Year 2021 Results : Almirall delivers high end of the 2021 upgraded guidance with solid performance from growth drivers
Almirall's Full-Year 2021 Results : Almirall delivers high end of the 2021 upgraded guidance with solid performance from growth drivers PR Newswire
21.02.22 - PR Newswire
Almirall's Full-Year 2021 Results : Almirall delivers high end of the 2021 upgraded guidance with solid performance from growth drivers
Almirall's Full-Year 2021 Results : Almirall delivers high end of the 2021 upgraded guidance with solid performance from growth drivers PR Newswire
18.02.22 - PR Newswire
Almirall launches innovative Wynzora® CAL/BDP cream in Europe for the treatment of mild to moderate plaque psoriasis in adults including scalp
Almirall launches innovative Wynzora® CAL/BDP cream in Europe for the treatment of mild to moderate plaque psoriasis in adults including scalp PR Newswire
21.12.21 - PR Newswire
Almirall: Lebrikizumab demonstrated significant skin improvement and itch relief when combined with topical corticosteroids in people with atopic dermatitis in third Phase 3 study
Almirall: Lebrikizumab demonstrated significant skin improvement and itch relief when combined with topical corticosteroids in people with atopic dermatitis in third Phase 3 study ...
15.11.21 - PR Newswire
Almirall delivers solid nine months 2021 results and tightens its upgraded guidance
Almirall delivers solid nine months 2021 results and tightens its upgraded guidance PR Newswire
15.11.21 - PR Newswire
Almirall delivers solid nine months 2021 results and tightens its upgraded guidance
Almirall delivers solid nine months 2021 results and tightens its upgraded guidance PR Newswire
08.11.21 - PR Newswire
Almirall U.S. Supports The Skin Cancer Foundation's Mobile Skin Cancer Screening Program
Almirall U.S. Supports The Skin Cancer Foundation's Mobile Skin Cancer Screening Program PR Newswire
06.10.21 - PR Newswire
Almirall S.A.: Experts highlight the need to focus on psoriasis patients' wellbeing in clinical practice
Almirall S.A.: Experts highlight the need to focus on psoriasis patients' wellbeing in clinical practice PR Newswire
27.09.21 - PR Newswire
Almirall Launches Klisyri®▼(Tirbanibulin) for the Treatment of Actinic Keratosis in Europe
Almirall Launches Klisyri®▼(Tirbanibulin) for the Treatment of Actinic Keratosis in Europe PR Newswire
16.08.21 - PR Newswire
Lebrikizumab significantly improved skin clearance and itch in people with moderate-to-severe atopic deramatitis in two Phase 3 trials
Lebrikizumab significantly improved skin clearance and itch in people with moderate-​to-severe atopic deramatitis in two Phase 3 trials PR Newswire
26.07.21 - PR Newswire
Almirall delivers robust H1 performance and increases full-year guidance
Almirall delivers robust H1 performance and increases full-year guidance PR Newswire
26.07.21 - PR Newswire
Almirall delivers robust H1 performance and increases full-year guidance
Almirall delivers robust H1 performance and increases full-year guidance - Robust business performance with significant growth in Core EBITDA: Core Net Sales €415.5 MM (+8% ...
12.06.12 - PR Newswire
Legg Mason Reports Assets Under Management For May 2012
Legg Mason Reports Assets Under Management For May 2012 PR Newswire

Newssuche

Videos

07.05.24 +7,29%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »